NFκB抗凋亡介导肺腺癌群集耐药
肿瘤,,肿瘤;抗药性;NFκB;脱噬作用,0引言,1材料和方法,2结果,3讨论,【参考文献】
NFκB mediates multicellular drug resistance of lung adenocarcinoma by antiapoptosisHE JianMing, LIANG HouJie, HUANG HaiHui, HU ShaoYi, BIAN ZhiHeng
Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
【Abstract】 AIM: To explore the role and probable mechanism of NFκB signal transduction in the multicellular drug resistance of lung adenocarcinoma. METHODS: Multicellular spheroids (MCS) were employed to simulate cellcell adhesion in the malignant mass. We compared the sensitivity of MCS to Adriamycin ( ADM ) with that of monolayer cells (MC) before and after blocking the activity of NFκB by adding NFκB inhibitor SN50. The activity of NFκB was analyzed by electrophoretic mobility shift assay and apoptosis was detected by flow cytometry and PI (propidiumiodium) staining. Bcl2 and BclxL expression levels were detected by flow cytometry and indirect immunofluorescent staining. RESULTS: Compared with MC, MCS had more than two layers of cells and had more extensive and compact cell adhesion. MCS were more resistant to adriamycin, and their NFκB activity, Bcl2 and BclxL expressions were much higher. After treatment with adriamycin (ADM), the NFκB activity of the cells increased. When NFκB was blocked, cells, especially those grown as MCS, became more sensitive to ADM and apoptosis increased while Bcl2 and BclxL expression decreased. CONCLUSION: NFκB plays an important role in multicellular resistance by upregulating BclxL and Bcl2 and suppressing apoptosis. ......
您现在查看是摘要页,全文长 10663 字符。